Amanote Research
Register
Sign In
FRI0248 Incidence of Melanoma in Patients With Rheumatoid Arthritis Treated With Tocilizumab
doi 10.1136/annrheumdis-2017-eular.1314
Full Text
Open PDF
Abstract
Available in
full text
Date
June 1, 2017
Authors
S Gale
J Wang
JM Nebesky
AT Linke
E Berber
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism
Related search
Incidence of Gastrointestinal Perforations in Patients With Rheumatoid Arthritis Treated With Tocilizumab From Clinical Trial, Postmarketing, and Real-World Data Sources
Rheumatology and Therapy
Laboratory and Febrile Features After Joint Surgery in Patients With Rheumatoid Arthritis Treated With Tocilizumab
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis
Archives of Rheumatology
Rheumatology
Autoantibody Formation in Patients With Rheumatoid Arthritis Treated With Anti-TNF
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Economic Evaluation of Tocilizumab Monotherapy vs Adalimumab Monotherapy in Patients With Rheumatoid Arthritis in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients With Rheumatoid Arthritis in Japan
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Macrocytic Anaemia in Patients Treated With Sulphasalazine for Rheumatoid Arthritis.
BMJ
Immunotherapy of Tocilizumab for Rheumatoid Arthritis
Journal of Clinical & Cellular Immunology
